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Abstract 
 
Introduction 
There is evidence that temporary defunctioning stoma formation in patients undergoing 
anterior resection reduces the risk of anastomotic leakage. The aim of the present study was 
to investigate the relationship between stoma formation, the postoperative systemic 
inflammatory response and complications following anterior resection for rectal cancer.   
 
Methods 
Data was recorded prospectively for patients who underwent anterior resection for 
histologically proven rectal cancer, from 2008 to 2015 at a single centre, n=167. Patients had 
routine preoperative and postoperative blood sampling including serum C-reactive protein 
(CRP). Postoperative complications including anastomotic leakage were recorded.  
 
Results 
Of the 167 patients, the majority were male (61%) and over 65 years old (56%) with node 
negative disease (60%).  36 patients (22%) underwent preoperative neoadjuvant treatment. 
100 patients (60%) had a stoma formed at the time of surgery.  Stoma formation was 
significantly associated with male sex (69% vs. 50%, p=0.017), neoadjuvant 
chemoradiotherapy (30% vs 9%, p=0.001) and open surgery (71% vs. 55%, p=0.040).  Of 
those 100 patients who had a stoma formed, 80 had it reversed. Permanent stoma was 
significantly associated with increasing age (p=0.011), exceeding the established CRP 
threshold of 150mg/L on postoperative day 4 (67% vs 37%, p=0.039), higher incidence of 
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postoperative complications (76% vs 47%, p=0.035), anastomotic leakage (24% vs 2%, 
p=0.003) and higher Clavien Dindo score (p=0.036).   
 
Conclusions 
There was no significant association between stoma formation during anterior resection and 
the postoperative systemic inflammatory response. However, in these patients both the 
postoperative systemic inflammatory response and complications were associated with 
permanent stoma.  
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Highlights 
 Postoperative inflammatory response associated with morbidity following colorectal 
surgery 
 No association with temporary stoma formation following anterior resection for rectal 
cancer.   
 Both inflammatory response and complications were associated with permanent 
stoma. 
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1. Introduction 
 
Rectal cancer is one of the most prevalent cancers diagnosed in the Western world [1]. 
Anterior resection with total mesorectal excision (TME) is the preferred surgical technique, 
to preserve the anal sphincter and avoid a permanent colostomy where abdominoperineal 
resection is not required [2]. However, anterior resection is associated with increased risk of 
anastomotic leakage, a major complication of this type of rectal surgery, when compared to 
resection of colorectal cancer in other locations [3].   Furthermore, anastomotic leakage has 
been indicated to be associated with increased risk of local recurrence and decreased short 
and long term survival of patients who have undergone potentially curative resection [4-5]. 
 Recent evidence suggests that the postoperative systemic inflammatory response, 
measure by C-reactive protein (CRP), is important in both short and long term outcomes of 
colorectal patients and that it may be a causal factor in development of postoperative 
complications [6-10]. A recent comprehensive review has suggested that CRP concentrations 
exceeding 150mg/L on postoperative days 3 to 5 should alert clinicians to the possible 
development of postoperative complications, including anastomotic leakage, precluding early 
discharge [11].  
Several studies have suggested that construction of a defunctioning stoma in patients 
who are undergoing anterior resection reduces the incidence of postoperative complications, 
including anastomotic leakage, and reoperation [12-14].  Although it has traditionally been 
thought that this reduction in anastomotic leak rate is due to diversion of the faecal stream, it 
may be that the formation of a stoma attenuates the magnitude of the postoperative systemic 
inflammatory response and that it is through this mechanism by which they reduce the rate of 
postoperative complications. 
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Therefore, the aim of the present study was to investigate the relationship between 
defunctioning stoma formation, and reversal, the magnitude of the postoperative systemic 
inflammatory response, and complications in rectal cancer patients who have undergone 
anterior resection.  
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2. Patients and methods 
 
2.1 Patients 
Patients with histologically proven rectal cancer, who underwent anterior resection, between 
February 2008 and April 2015 at a single centre were included in the study.  Patients who 
underwent emergency surgery, palliative procedures, or who had existing inflammatory 
conditions were excluded.  Neoadjuvant treatment was offered to patients with histologically 
proven, locally advanced (T3-T4, borderline operable or inoperable) rectal tumours following 
discussion at a multi-disciplinary colorectal oncology meeting.   
 All patients received prophylactic antibiotics and venous thromboprophylaxis prior to 
the induction of anaesthesia as per hospital policy.  All patients had a primary anastomosis 
formed and the decision to form a proximal defunctioning stoma, with temporary intent, was 
at the discretion of the operating surgeon.  Patients had routine preoperative blood sampling 
including a full blood count (FBC), serum CRP and albumin concentration.   
 On each postoperative day patients were clinically assessed and had blood samples, 
including serum CRP, obtained routinely until discharged.  Further postoperative 
investigation and intervention was at the discretion of the patient’s surgical team who were 
not blinded to blood results.  This study was approved by the West of Scotland Research 
Ethics Committee.     
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2.2 Methods 
Data was collected prospectively in a database, anonymised, and subsequently analysed 
retrospectively.  Recorded information included patient demographics, clinicopathological, 
operative data, postoperative data, and date of stoma reversal if applicable. 
Serum concentrations of CRP (mg/L) were measured using an autoanalyzer 
(Architect; Abbot Diagnostics, Maidenhead, UK) with a lower detectable limit of 0.2 mg/L as 
was serum albumin (normal range 35-50g/L).  The preoperative modified Glasgow 
Prognostic Score (mGPS) was calculated in patients for whom serum CRP and albumin 
concentrations were available [15].  Exceeding the established postoperative CRP threshold 
of 150mg/L on postoperative days 3or 4 was recorded [11]. 
Postoperative complications were recorded up to and including the first follow up 
clinic, usually 6 weeks after discharge from hospital.  Infective complications were 
categorised as described elsewhere and summarised here briefly [8]. Wound (superficial 
surgical site) infection was defined as the presence of pus either spontaneously discharging 
from the wound or requiring drainage.  Deep surgical site infection was defined as surgical or 
image-guided drainage of intra-abdominal pus.  Anastomotic leak was defined as 
radiologically verified fistula to bowel anastomosis or diagnosed at laparotomy. Pneumonia 
was defined by fever above 38.5oC and consolidatory chest X-ray findings requiring 
antibiotic treatment.  Septicaemia was defined by the presence of sepsis combined with 
positive blood culture.  Urinary tract infection was only included if complicated by 
septicaemia and confirmed with positive urine culture. Complications were also classified by 
severity using the Clavien Dindo grade [16].   
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2.3 Statistical Analysis 
Categorical data were compared using the Chi square test.  Continuous data were non-normal 
so were displayed as medians and ranges, and were compared using the Mann-Whitney U 
test.  Significant differences were found in the rate of defunctioning stoma formation 
dependent on whether a laparoscopic or open surgical approach was used and so a post hoc 
subgroup analysis was performed in those patients who underwent open surgery.  Binary 
logistic regression of factors associated with permanent stoma was performed using a 
backward conditional model with removal of terms with p>0.05 at each step.  Statistical 
analyses were performed using IBM SPSS version 22 for Windows (Chicago, IL, USA).  
Two tailed p values <0.05 were considered statistically significant.  Missing data were 
excluded from analysis.           
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3. Results 
3.1 Patients 
After exclusion of those patients who underwent emergency or palliative surgery, or with 
existing inflammatory disease, 869 resections for colorectal cancer were performed during 
the study period, with 251 patients undergoing surgery for rectal cancer, of which 167 
patients underwent anterior resection and were included in the study. The majority were male 
(102, 61%), over 65 years old (93, 56%) and underwent open surgery (109, 65%).  36 
patients (22%) underwent neoadjuvant chemoradiotherapy.  7 patients (4%) had metastatic 
disease at the time of surgery, all located in the liver, of which 4 underwent synchronous 
resection, and 3 underwent staged liver resection following anterior resection.  79 patients 
(47%) developed a postoperative complication of which 73 were infective. There were 12 
reported anastomotic leaks (7%).  There were 3 deaths (2%) within the immediate 
postoperative period. Of the 79 patients who developed a postoperative complication, 61 
were Clavien Dindo grade 1-2 and 18 were Clavien Dindo grade 3-5. 100 (60%) patients who 
underwent anterior resection had a defunctioning stoma formed. 
 
3.2 Variables associated with stoma formation 
Defunctioning stoma formation (Table 1) was significantly associated with male sex (69% vs. 
50%, p=0.017), neoadjuvant chemoradiotherapy (30% vs 9%, p=0.001) and open surgery 
(71% vs. 55%, p=0.040). There was no significant association between stoma formation and 
other patient factors including age, BMI, smoking status, ASA grade or TNM staging. No 
significant association was found between stoma formation and preoperative mGPS.  There 
was no significant association between stoma formation and CRP on postoperative days 3 or 
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4.  There was no significant difference in the incidence or severity of postoperative 
complication, or in the rate of anastomotic leak between either group.   
 
3.3 Variables associated with stoma formation in patients who underwent an open operation 
Within the patients who underwent open surgery, there was significant association (Table 2) 
between stoma formation and neoadjuvant chemoradiotherapy (34% vs 14%, p=0.029). There 
was no significant association between stoma formation and other patient factors including 
age, BMI, smoking status, ASA grade, TNM staging or operation type. There was no 
significant difference in CRP between the patient groups with and without stoma on 
postoperative days 3 or 4 (Figure 1). There was no significant association between stoma 
formation and the incidence or severity of postoperative complications.  
 
3.4 Variables associated with permanent stoma in patients undergoing open surgery 
Of the 71 patients who had open surgery and a defunctioning stoma formed, 53 (75%) had 
their stoma reversed.  The median time from anterior resection to stoma reversal was 8 
months (range 1-23).  Permanent stoma was significantly associated with increasing age 
(p=0.011), higher CRP on postoperative days 3 (212mg/L vs 144mg/L, p=0.048) and 4 
(179mg/L vs 128mg/L, p=0.044), the proportion of patients exceeding the established CRP 
threshold of 150mg/L on postoperative day 4 (67% vs 37%, p=0.039), a higher incidence of 
postoperative complications (76% vs 47%, p=0.035), anastomotic leakage (24% vs 2%, 
p=0.003) and higher Clavien Dindo grade (p=0.036).  However, there was no significant 
association between permanent stoma and patient factors including age, BMI, smoking status, 
ASA grade, TNM staging and neoadjuvant chemoradiotherapy.  At binary logistic regression 
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of those factors found to be significantly associated with permanent stoma, increasing age 
(OR 3.46, 95% CI 1.46-8.12, p=0.005), and Clavien Dindo grade (OR 3.00, 95% CI 1.14-
7.84, p=0.025) remained significantly independently associated.  
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4. Discussion 
The results of the present study suggest that temporary defunctioning stoma formation is not 
associated with the magnitude of the postoperative systemic inflammatory response or 
complications in patients who have undergone anterior resection for rectal cancer.  However 
they do suggest that increasing age, inflammation and a complicated postoperative course 
increases the likelihood of having a permanent stoma. 
In keeping with some earlier published reports, the present study reports that males 
and patients who have undergone neoadjuvant chemoradiotherapy are more likely to have a 
defunctioning stoma at anterior resection [17, 18]. In addition, the present study is also in 
agreement with a single study which demonstrated that stoma formation is not associated 
with body mass index [19]. The present study also reports that stoma formation is not 
associated with ASA grade, TNM staging and age group which is in keeping with other 
published work [17].  
To the author’s knowledge, there has been no prior study examining the association 
between stoma formation and preoperative systemic inflammatory status. There is limited 
evidence which examines the association between stoma formation the postoperative 
systemic inflammatory response; a single study which investigated CRP on the first and third 
postoperative day which reported a significant difference in CRP on postoperative day 3 [20]. 
In contrast, the present study reported no association between CRP levels on postoperative 
days 3 or 4 between patient groups with and without stoma.  The anastomotic leak rate in the 
present study was around half that (8%) of Ma and colleagues study (16%) which may in part 
explain this difference.    
The present study demonstrates no association between stoma formation and 
postoperative complications when all included patients were considered. However, the 
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present study reports a trend towards reduced incidence of anastomotic leakage in patients 
with stoma, although it did not reach statistical significance due to cohort size.  As surgical 
approach is a significant confounder with regard to the postoperative systemic inflammatory 
response, and was associated with the incidence of stoma formation in the present study, 
subgroup analysis was performed.   
It was of interest that there was no significant association between stoma formation 
and patient factors such as BMI, ASA, or smoking status.  There was however a significant 
association between stoma formation and neoadjuvant treatment although recent evidence 
suggests no reduction in postoperative complication, unplanned reoperation or mortality in 
patients who have a stoma formed following neoadjuvant treatment [21].  It may be that 
perceived differences in rectal dissection in patients who have had neoadjuvant treatment 
prompts some surgeons to create more temporary defunctioning stomas in this patients group. 
The present study is in line with a few published studies, reporting that permanent 
stoma is associated with older patients (age<65) [22] and higher incidence of postoperative 
complications, including anastomotic leakage [22-26]. The present study also reports that 
permanent stoma is associated with higher CRP on postoperative days 3 and 4, and a higher 
proportion of patients who breached the CRP threshold on postoperative days 4.  Given the 
greater anastomotic leak rate and higher Clavien Dindo grade this may simply reflect that 
patients experiencing significant complications are less likely to have subsequent stoma 
reversal, which would be in keeping with the result of the binary logistic regression analysis. 
However, to the author’s knowledge, there have not been any previous studies that have 
examined the relationship between postoperative systemic inflammatory response and 
permanent stoma.  Furthermore, the question of whether the magnitude of the postoperative 
systemic inflammatory response is causal, or merely an epiphenomenon of postoperative 
complications remains unanswered.  
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It is therefore possible that the rate of postoperative complications, and thus the 
likelihood of having a permanent stoma after anterior resection, could be reduced by 
attenuation of the magnitude of the postoperative systemic inflammatory response. This 
hypothesis may be tested by prospective trials of factors understood to attenuate the 
magnitude of the postoperative systemic inflammatory response, including the administration 
of preoperative corticosteroids [26], non-steroidal anti-inflammatory drugs and statins [27], 
and by carrying out laparoscopic surgery [28].   
The main limitation of the present study is the relatively small number of patients 
undergoing anterior resection as a proportion of all patients operated on for colorectal cancer 
during the period.  However, this group was chosen, rather than the inclusion of resections at 
other locations, due the relatively high rate of stoma formation and to allow direct 
comparison.  Furthermore, the retrospective nature of the study means that not all patients 
had CRP measured in the pre and postoperative periods studied.   
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5. Conclusions 
In conclusion, the present study reports a lack of association between stoma formation and 
postoperative systemic inflammatory response in patients who have undergone anterior 
resection for rectal cancer.  However, both the systemic inflammatory response and 
postoperative complications were associated with permanent stoma.  
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Tables and footnotes 
Table 1: Relationship between temporary defunctioning stoma formation and 
clinicopathological variables in patients undergoing elective anterior resection of rectal 
cancer (n=167)  
Characteristic All Stoma P 
No Yes 
Sex (male/female) 102/65 33/34 69/31 0.017 
Age (<65/65-74/>74) 74/69/24 27/31/9 47/38/15 0.566 
BMI (median/range)/ kg/m2 27 (17-50) 27 (19-42) 26 (17-50) 0.842 
ASA Grade (1/2/3/4) 44/71/40/2 13/29/19/0 31/42/21/2 0.235 
Smoking (no/ex/current) 77/66/23 32/27/8 45/39/15 0.839 
Preoperative mGPS (0/1/2) 135/14/9 51/8/4 84/6/5 0.356 
Neoadjuvant 
chemoradiotherapy (yes/no) 
36/131 6/61 30/70 0.001 
Operative (laparoscopic/open) 58/107 29/36 29/71 0.040 
TNM stage (0/1/2/3/4) 4/40/56/58/7 0/19/26/18/2 4/21/30/40/5 0.141 
     
     
POD 3 CRP 
(median,range.mg/L) 
147 (2-386) 143(21-354) 149(2-386) 0.464 
POD 4 CRP 
(median,range.mg/L) 
128 (2-425) 133(20-425) 124(2-408) 0.495 
POD 3 CRP >150mg/L (yes/no) 70/80 25/34 45/46 0.396 
POD 4 CRP >150mg/L (yes/no) 55/84 19/31 36/53 0.777 
     
Any postoperative complication 
(yes/no) 
79/82 29/35 50/47 0.439 
Anastomotic leakage (yes/no) 12/149 7/57 5/92 0.172 
Clavien Dindo Classification 
(0/1-2/3-5) 
82/61/18 
35/21/8 47/40/10 0.784 
     
Adjuvant therapy (yes/no) 41/126 16/51 25/75 0.704 
ASA American Society of Anaesthesiology score, BMI Body Mass Index, CRP C-reactive protein, mGPS 
modified Glasgow Prognostic Score 
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Table 2: Relationship between temporary defunctioning stoma formation and 
clinicopathological variables in patients undergoing elective, open anterior resection of rectal 
cancer (n=107) 
Characteristic All Stoma P 
No Yes 
Sex (male/female) 63/44 18/18 45/26 0.184 
Age (<65/65-74/>74) 47/44/16 15/17/4 32/27/12 0.580 
BMI (median/range)/ kg/m2 26 (17-50) 27(20-42) 26 (17-50) 0.842 
ASA Grade (1/2/3/4) 29/46/26/1 6/18/10/0 23/28/16/1 0.309 
Smoking (no/ex/current) 49/42/15 19/13/4 30/29/11 0.597 
Preoperative mGPS (0/1/2) 89/7/8 26/4/4 63/3/4 0.175 
Neoadjuvant 
chemoradiotherapy (yes/no) 
29/78 5/31 24/47 0.029 
TNM stage (0/1/2/3/4) 3/23/31/43/6 0/7/13/13/2 3/16/18/30/4 0.589 
     
POD 3 CRP 
(median,range.mg/L) 
152 (37-386) 148(37-354) 153(40-386) 0.829 
POD 4 CRP 
(median,range.mg/L) 
134 (2-408) 136(20-369) 133(2-408) 0.752 
POD 3 CRP >150mg/L (yes/no) 51/47 16/18 35/29 0.472 
POD 4 CRP >150mg/L (yes/no) 39/57 10/20 29/37 0.327 
     
Any postoperative complication 
(yes/no) 
57/49 19/17 38/32 0.883 
Anastomotic leakage (yes/no) 8/98 3/33 5/65 0.826 
Clavien Dindo Classification 
(0/1-2/3-5) 
49/45/12 17/15/4 32/30/8 0.785 
     
Adjuvant therapy (yes/no) 27/80 10/26 17/54 0.813 
ASA American Society of Anaesthesiology score, BMI Body Mass Index, CRP C-reactive protein, mGPS 
modified Glasgow Prognostic Score 
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Table 3: Relationship between permanent stoma and clinicopathological variables in patients 
with stoma formation during elective, open anterior resection of rectal cancer (n=71) 
Characteristic All Permanent Stoma P 
No Yes  
Sex (male/female) 45/26 34/19 11/7 0.817 
Age (<65/65-74/>74) 32/27/12 29/18/6 3/9/6 0.011 
BMI (median/range)/ kg/m2 26(17-50) 27(17-50) 25(19-38) 0.579 
ASA Grade (1/2/3/4) 23/28/16/1 18/20/12/1 5/8/4/0 0.884 
Smoking (no/ex/current) 30/29/11 23/19/10 7/10/1 0.241 
Preoperative mGPS (0/1/2) 63/3/4 46/3/3 17/0/1 0.579 
Neoadjuvant chemoradiotherapy 
(yes/no) 
24/47 19/34 5/13 0.532 
TNM stage (0/1/2/3/4) 3/16/17/30/4 2/13/13/22/3 1/3/4/8/1 0.974 
     
POD 3 CRP 
(median,range.mg/L) 
152(37-386) 144(40-386) 212(55-333) 0.048 
POD 4 CRP 
(median,range.mg/L) 
134(2-408) 128(2-388) 179(33-408) 0.039 
POD 3 CRP >150mg/L (yes/no) 35/29 24/25 11/4 0.097 
POD 4 CRP >150mg/L (yes/no) 29/37 19/32 10/5 0.044 
     
Any postoperative complication 
(yes/no) 
38/32 25/28 13/4 0.035 
Anastomotic leakage (yes/no) 5/65 1/52 4/13 0.003 
Clavien Dindo Classification 
(0/1-2/3-5) 
32/30/8 28/22/3 4/8/5 0.036 
     
Adjuvant therapy (yes/no) 17/54 14/39 3/15 0.510 
ASA American Society of Anaesthesiology score, BMI Body Mass Index, CRP C-reactive protein, mGPS 
modified Glasgow Prognostic Score 
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Figures and legends 
Figure 1: Impact of stoma formation on postoperative systemic inflammation following 
elective, open anterior resection of rectal cancer 
 
 
 
 
 
 
 
 
